Bamlanivimab
Product Specifications
CAS Number
2423943-37-5
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Bamlanivimab, an Anti-Human SARS-CoV-2 monoclonal antibody (mAb), was the first of its kind to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020 for COVID-19 treatment. However, its authorization was withdrawn in April 2021 due to emerging SARS-CoV-2 variants resistant to the antibody [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS746384-03 5x 96 Well
Chicken Sterol Regulatory Element Binding Proteins ELISA Kit
Ask
View Details MBS746384-04 10x 96 Well
Chicken Sterol Regulatory Element Binding Proteins ELISA Kit
Ask
View Details